Analysis of medical prescribing practices for hepatitis B serology tests

Insights

Most hepatitis B virus (HBV) serology test requests in France do not follow guidelines, leading to unnecessary costs. Improving physician adherence to HBV testing guidelines is crucial for accurate diagnosis and cost-efficiency.

Area of Science:

  • Hepatology
  • Clinical Pathology
  • Public Health

Background:

  • Hepatitis B virus (HBV) serology tests are vital for diagnosis and management.
  • Adherence to French prescription guidelines for HBV serology is essential for appropriate medical care and resource allocation.

Purpose of the Study:

  • To evaluate compliance with French HBV serology prescription guidelines.
  • To determine the financial impact of inappropriate HBV test requests.
  • To assess the accuracy of physicians' interpretation of HBV serology results.

Main Methods:

  • A cross-sectional practice inquiry involving 118 prescriptions for HBV serology tests.
  • Prospective data collection from laboratory heads and prescribing physicians in June 2005.
  • Analysis of prescription details, clinical indications, and physician interpretations.

Main Results:

  • 74% of prescriptions failed to comply with current guidelines, with 45% exhibiting vague wording.
  • Inappropriate HBV serology test requests resulted in an additional cost of €43.41 per prescription.
  • Physician interpretation of test results was rated as excellent in 27%, fair in 59%, and false in 14% of cases.

Conclusions:

  • Significant non-compliance with HBV serology testing guidelines necessitates improved application in clinical practice.
  • Enhanced in-service training for physicians on HBV testing protocols is recommended.
  • Addressing guideline non-adherence can reduce healthcare costs and improve patient management.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...